-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Maintains Overweight on Solventum, Raises Price Target to $99

Benzinga·02/27/2026 13:34:05
Listen to the news
Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $97 to $99.